GE to Acquire Sweden's Biacore
GE's (GE) health care unit is offering to buy Sweden's Biacore International, a maker of tools for protein research, for about $438 million.
A part of Pfizer (PFE) owns 41% of Biacore and said it supports the transaction. Biacore employs about 300 people worldwide, and operates a research and development and manufacturing facilities in Uppsala, Sweden, where GE Healthcare Life Sciences is based.
"GE Healthcare and Biacore have a shared vision on the importance of life sciences research to future developments in improving global health care," said Joe Hogan, president and CEO of the GE division. "Life sciences is a key area of growth for GE Healthcare, and Biacore is highly complementary and synergistic with our existing protein sciences business."
Founded in 1984, Biacore's systems generate data on the interactions between proteins and other molecules, including small molecules such as drug candidates. Biacore's products are used in areas such as antibody characterization, proteomics immunogenicity and production.Shares of GE were down 7 cents at $33.65. Pfizer slipped 16 cents to $22.90.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV